Abiopharma

(99% Neutral) SCWorx Corp. (WORX) Files Form 8-K

Best iPhone Accessories For 2026

Best Mechanical Keyboards (2026)

Best Wireless Headphones (2026)

Best Inkjet Printers For 2026

Best Office Accessories In 2026

Tornehl Tobin 🔴 sold 9.5K shares (3 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) at $90.02 Transaction Date: Dec 08, 2025 | Filing ID: 000026

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN SUCCINATE. Decision date: 12/09/2025

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN SUCCINATE. Decision date: 12/09/2025

Labeling changes approved for GLAXOSMITHKLINE. Active ingredient: SUMATRIPTAN. Decision date: 12/09/2025

CREGG ROGER A 🟡 adjusted position in 0 shares (1 derivative) of WESTLAKE CORP (WLK) Transaction Date: Dec 10, 2025 | Filing ID: 314045

Director Manning Paul 🔴 sold 123.8K shares (3 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) at $90.02 ($1.1M) Transaction Date: Dec 08, 2025 | Filing ID: 000022

Manning John J 🔴 sold 16.9K shares (3 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) at $90.02 Transaction Date: Dec 08, 2025 | Filing ID: 000020

📋 Floyd Petersen (Director) plans to sell 2K shares of Amphastar Pharmaceuticals, Inc. (at $25.00 each, total $43K) Filed: Dec 10, 2025 | ID: 001063

Jones Amy Schmidt 🔴 sold 14.1K shares (3 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) at $90.02 Transaction Date: Dec 08, 2025 | Filing ID: 000018